Grant Bogle Email & Phone Number
@epizyme.com
LinkedIn matched
Who is Grant Bogle? Overview
A concise factual answer block for searchers comparing this professional profile.
Grant Bogle is listed as Founder and Principal at CSP Advisors LLC, based in Boston, Massachusetts, United States. AeroLeads shows a work email signal at epizyme.com and a matched LinkedIn profile for Grant Bogle.
Grant Bogle previously worked as Member Board of Directors at Nuvalent, Inc. and Member Board of Directors at Myrobalan Therapeutics. Grant Bogle holds Fellow, Advanced Leadership Initiative from Harvard University.
Email format at CSP Advisors LLC
This section adds company-level context without repeating Grant Bogle's masked contact details.
AeroLeads found 1 current-domain work email signal for Grant Bogle. Compare company email patterns before reaching out.
About Grant Bogle
Senior biotechnology executive and board member with proven strategic, financial, and operational expertise as demonstrated by the breadth and depth of experience gained throughout my career within biotechnology and healthcare service companies. Specific experience and expertise in corporate governance, financial strategy and execution, business development, P&L management and team leadership and development.
Listed skills include Strategy, Marketing Strategy, Sales Operations, Marketing, and 12 others.
Grant Bogle's current company
Company context helps verify the profile and gives searchers a useful next step.
Grant Bogle work experience
A career timeline built from the work history available for this profile.
Founder And Principal
CSP Advisors is an independent advisory firm supporting oncology focused biotechnology companies approaching commercialization.
Board Member
Board Member
President & Chief Executive Officer
Appointed as CEO in August 2021 after serving on board for 24 months. Reduced operating costs by ~25%, raised $85 million in a bear market, and accelerated sales of TAZVERIK (tazemetostat) facilitating the opportunity for a strategic transaction. Renegotiated the debt obligation of the company which would have resulted in an 18 month delay in principal repayment on terms favorable to the company (not implemented due to sale of the company). Led sale of the company to Ipsen SA resulting in repayment of debt obligation, value for shareholders and employment opportunities for Epizyme associates.
Member Board Of Directors
Company acquired by Ipsen SA on August 12, 2022
Senior Vice President, Chief Commercial Officer
Led the commercial launch of ZEJULA (niraparib) for ovarian cancer resulting in global revenue of $230MM in 2018, less than 2 years post initial launch.• Member of the TESARO Executive Committee and Officer of the Company• Built US commercial infrastructure from small pre-launch team to approximately 175 field-based and 30 headquarter-based associates over four years• Senior commercial member of the Joint Steering Committee with Janssen Pharmaceuticals supporting development of ZEJULA for prostate cancer• Supported the integration of TESARO into GSK through June 2019
Senior Vice President, Pharmaceutical And Biotech Solutions
Executive Committee member with P&L accountability for US Oncology Research, Reimbursement, Access and Hub Services and Informatics. • Returned US Oncology research to profitability over 3 years by revising the pricing structure, growing study volume by 30% and reducing costs through improved operational efficiency and technology• Integrated two legacy reimbursement businesses with a total of 800 employees, outsourcing IT services to reduce costs and returning the business to profitability in two years• Actively participated in the transaction that resulted in the sale of US Oncology to McKesson
Senior Vice President Of Operations, Northeast Region
Responsible for the financial and operational oversight of ten diversified US Oncology community practices located in the Northeast. Worked closely with the practice presidents along with the P&T Committee of US Oncology.
Senior Vice President, Sales And Marketing
Lead sales and marketing of VELCADE (bortezomib), a first-in-class IV drug for the treatment of multiple myeloma in the US, growing US sale revenue to over $220M three years post launch.
President
Vice President, Sales And Marketing Services
Vice President, Sales And Marketing
Director Of Sales
Midwest Regional Sales Manager
Product And Sales Management
Grant Bogle education
Fellow, Advanced Leadership Initiative
Master Of Business Administration (Mba), Business/Commerce, General
Ba, Economics
Frequently asked questions about Grant Bogle
Quick answers generated from the profile data available on this page.
What company does Grant Bogle work for?
Grant Bogle works for CSP Advisors LLC.
What is Grant Bogle's role at CSP Advisors LLC?
Grant Bogle is listed as Founder and Principal at CSP Advisors LLC.
What is Grant Bogle's email address?
AeroLeads has found 1 work email signal at @epizyme.com for Grant Bogle at CSP Advisors LLC.
Where is Grant Bogle based?
Grant Bogle is based in Boston, Massachusetts, United States while working with CSP Advisors LLC.
What companies has Grant Bogle worked for?
Grant Bogle has worked for Csp Advisors Llc, Nuvalent, Inc., Myrobalan Therapeutics, American School For The Deaf, and Twin Lakes Association Of Salisbury Inc.
How can I contact Grant Bogle?
You can use AeroLeads to view verified contact signals for Grant Bogle at CSP Advisors LLC, including work email, phone, and LinkedIn data when available.
What schools did Grant Bogle attend?
Grant Bogle holds Fellow, Advanced Leadership Initiative from Harvard University.
What skills is Grant Bogle known for?
Grant Bogle is listed with skills including Strategy, Marketing Strategy, Sales Operations, Marketing, Leadership, Business Development, Budgets, and Sales.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial